Past medical history: Significant for hemorrhoids.
Past surgical history: Right craniotomy in March 2003.
Gynecological history: Menarche at age 13. Patient is gravida 1 para 1 and has never been on hormone replacement therapy.
Family history: Father is 78 years old with a history of stroke diabetes and alcoholism. Mother recently died at age 72 from congestive heart failure and hypertension. The patient has 1 sister and 3 brothers ages 27 to 54 who are alive and well.
Social history: Patient is married. She has a 22-monthold son. She works in a managerial position in the human resources section of a downtown department store. She denies any tobacco use. She previously drank alcohol a couple times per month. No drug use.
Allergies: No known drug allergies.
Medications: Dexamethasone 4 mg every day. Has ceased use of oral contraceptives since beginning Temodar.
Review of Systems
General: Patient states that her weight has been stable. Her appetite is excellent. She describes a normal sleeping pattern with no complaints of insomnia but admits to sleeping on the couch a lot during the day. 
Glioblastoma Multiforme
Genitourinary: No urinary complaints.
Musculoskeletal: No myalgias or arthralgias.
Neurological: Patient has had 2 episodes of headaches in the past week. The second episode required her to increase her steroid dose, and then it resolved. Her husband has noted some short-term memory problems, which have been a bit better since her surgery. In particular, she has a hard time with directions, planning, and remembering dates of her doctor visits, and she is having a hard time finding certain words. She denies any dizziness.
Hematological:
No easy bruising or easy bleeding.
Psychiatric: Patient admits to feeling very scared and a bit anxious about her current situation.
Oral:
Patient reports no problems with gums or teeth.
Physical Examination
This a very pleasant 36-year-old female, alert and well oriented and in no acute distress. Cardiovascular: Regular heart rate and rhythm with S1 and S2 sounds present.
Lungs: Breath sounds are clear to auscultation bilaterally. No crepitations or wheezing.
Abdomen: Soft and nontender, no ascities, no masses palpated, no hepatosplenomegaly. Normal bowel sounds heard.
Breasts: Breast exam is deferred.
Musculoskeletal: Patient ambulates without assistance. There is no extremity edema or tenderness. Normal range of motions for all joints. Lower extremity pulses were normal.
Neurological:
No focal deficits. Her recent remote and immediate memory does appear intact. However, upon following directions in the office, she was a bit confused when asked to put on a blue gown opening in the front and undressing from the waist up. She left her turtleneck on and removed her jeans. Her Karnofsky performance status is 80%.
Dietary history: Patient has always enjoyed a typical American diet, including milk 3 times a day and meat twice per week. The patient craves sweets and chocolate. She eats 3 meals per day plus snacks, and her appetite is good with 90% of her meals at home. She has been trying to choose more organic foods. Her husband is critical of her diet and has been encouraging her to eat more healthy food.
Exercise history: Patient does not have a particular exercise regimen. However, she does walk daily and in the past used to run, dance, and lift weights weekly. She does not have any specific time set for exercise.
Environmental exposures: None. She adapts well to changing environments.
Sleep pattern: Patient routinely sleeps 8 to 10 hours per day. She does not have any problem falling asleep and does not have problems falling back to sleep after waking once in the night.
Life patterns and relationships: Patient states that she had a verbally and physically abusive childhood. Her father was an alcoholic, and she was scared and embarrassed of him. She describes herself as a kind and open person. She enjoyed her work, but had to stop work after her surgery. She has a very loving and friendly relationship with her husband. Reading and playing with her son reduces her stress and makes her relax. She had difficulty caring for her son after surgery, but after her recovery, she was able to take care of him. Her recent stressful events were death of a close family member and pregnancy.
Priorities: Associations/relationships with friends and family, acknowledgement of her work, security concerns, appearance, freedom from pain, libido, vitality and performance, and longevity. 
Sachin Dixit, MD

Neurooncology
The term glioblastoma multiforme (GBM) refers to a grade IV astrocytoma based on the World Health Organization classification system. 1 This is a primary brain tumor of glial cell lineage (the astrocyte). These cells act as the supporting cells for the neurons of the central nervous system. Gliomas are graded based on the presence of 4 characteristics: mitoses, nuclear atypia, microvascular proliferation, and necrosis. The GBM has all 4 features. These tumors are the most common type of glial tumor with an annual incidence of approximately 3 to 4 per 100,000 in the United States. 2 There is a male predominance (3 male:2 female). Peak age of onset is in the 6th to 7th decade of life.
GBMs of late life are usually de novo or primary GBMs (not occurring as a result of progression of a lower grade glioma). Primary GBMs are associated with genetic changes including an overexpression of the epidermal growth factor receptor gene, p16 deletion, and mutations of phosphatase and tensin homologues. 3, 4 GBMs can occur in younger adults but usually develop from a lower grade tumor (secondary GBM). Peak age of onset is in the fourth to fifth decade of life. They are associated with an abnormality of TP53 and overexpression of platelet-derived growth factor A and PDGF receptor α. 2 These tumors are less common than primary GBMs.
The case presented here is of a 36-year-old woman. Therefore, this is likely a secondary GBM with a TP53 mutation. Secondary GBMs can occasionally be diagnosed on magnetic resonance imaging (MRI) if there is nonenhancing and enhancing areas of the mass (indicating lower and higher grades of tumor, respectively). In this case, the tumor was enhancing and cystic, signifying an area of necrosis. There was mass effect and midline shift, giving a clue as to the tumor's aggressive nature and rapid growth.
GBMs can occur anywhere in the central nervous system, although they develop mostly in the cerebral hemispheres in adults. The patient has a right frontal lobe tumor but complains of word-finding difficulties. No aphasia is mentioned on physical exam, and her handedness is not mentioned. This symptom is likely related to her general cognitive dysfunction since right cerebral hemispheric dominance is rare. The tumor's specific location is probably anterior to the premotor and motor strip since the patient has no motor deficits. Since damage to the anterior frontal lobe does not cause focal deficits, the tumor could have been present for years without any clinical symptomatology. A recent malignant transformation and rapid growth could have resulted in the clinical presentation of headaches secondary to high intracranial pressure and mass effect.
Symptoms due to high intracranial pressure and mass effect are treated with dexamethasone or other corticosteroids. In emergency circumstances, mannitol, other diuretics, and hyperventilation may be used. Surgical resection is the definitive treatment. Steroids are usually weaned off (as tolerated) following surgery. Some patients also demonstrate seizure activity resulting from their tumor or associated hemorrhage. Prophylactic antiepileptic medication is not recommended for patients who have brain tumors and no history of seizures. 5 GBMs are officially diagnosed via histopathology. Although they have a characteristic MRI appearance, metastatic tumors, abscesses, and low-grade tumors (pilocytic and pleomorphic xantho-astrocytoma) can be difficult to distinguish. Tissue for histopathology is procured by biopsy or surgical resection. Gross total resection (leaving < 1 cc of tissue behind) improves survival time. 6, 7 Currently, the standard of care for treatment is surgical resection followed by radiotherapy and chemotherapy. Radiotherapy consists of fractionated conformal external beam radiation to a total of 60Gray over 6 weeks. 8 This patient was given temozolomide concurrently with radiotherapy. Temozolmide is an alkylating chemotherapy that is delivered orally. It is approved by the Food and Drug Administration for use in anaplastic astrocytoma at relapse. 9 Standard dosing is 150 to 200 mg per m 2 per day, days 1 through 5 of each 28-day cycle. At least 6 cycles of temozolomide are recommended, although patients can tolerate > 4 years of treatment (William R. Shapiro, personal communication, 2003) . Temozolomide has radiosensitizing properties; therefore, many neurooncologists start treatment on initiation of radiotherapy at 75 mg/m 2 every day for 6 weeks. 10 Dose-limiting toxicity is bone marrow suppression. Other common side effects include nausea, vomiting, constipation, and fatigue. This patient discontinued her use of oral contraceptives when she started temozolomide. This is not advisable. Even though many chemotherapies prohibit ovulation, patients have become pregnant while on this chemotherapy.
